Background and Aims: Two alkaline phosphatase isoforms, intestinal [IAP] and tissue non-specific alkaline phosphatase [TNAP], are coexpressed in mouse colon, with the latter predominating in colitis. We aimed to examine the role of TNAP in T lymphocytes, using heterozygous TNAP +/-mice [as TNAP -/-mice are non-viable]. Methods: In vitro primary cultures and in vivo T cell models using TNAP +/-mice were used.
Introduction
Alkaline phosphatases are a large family of enzymes distributed from bacteria to man, which cleave phosphate moieties with release of inorganic phosphate at alkaline pH. There are four main alkaline phosphatase [AP] isoforms: the intestinal [IAP], the placental, and the germ cell isoforms, which are tissue-specific, plus the tissue nonspecific alkaline phosphatase [TNAP] which is widely expressed. The TNAP gene in turn gives rise to three different enzyme variants that differ only in the glycosidic fraction, namely the liver, bone, and kidney isoforms, which are predominantly found in these organs. The tissue-specific AP forms are also glycosylated.
IAP has a pivotal role in intestinal homeostasis and health, and its expression and activity are modulated by the diet. IAP regulates lipid absorption across the apical membrane of enterocytes, 1 takes part in the regulation of bicarbonate secretion and of duodenal surface pH, 2, 3 limits bacterial translocation across the mucosal barrier, and detoxifies lipopolysaccharides [LPS] from Gram-negative bacteria, thereby attenuating LPS-mediated toxicity and inflammation. [4] [5] [6] IAP also preserves the normal homeostasis of intestinal microbiota preventing dysbiosis and infections of pathogenic bacteria. 7 Moreover, healthy people with low stool levels of IAP [less than 65.0 U/g stool] might have increased susceptibility to developing metabolic syndrome. In fact, it has been estimated that there is a 35% increased risk of diabetes with each 25 U/g decrease in stool IAP. 8 Furthermore, endogenous and orally supplemented IAP was found to prevent and reverse metabolic syndrome by inhibiting the absorption of endotoxin [LPS] in mice fed with a high fat diet. 9 TNAP has been widely studied due to its involvement in various liver, bone, and colonic disorders. In the liver, TNAP has an important role in the inhibition of bile secretion and the detoxification of bacterial LPS, and it is increased along with elevated LPS in cholestasis. 10 Additionally, TNAP is known to be essential for the development of bone and teeth. Hypophosphatasia is a condition which results from TNAP gene mutations that lead to accumulation of PP i in the extracellular matrix, which inhibits mineralisation, thereby causing an inheritable form of rickets in children or osteomalacia in adults. 11, 12 Furthermore, TNAP has been shown to be essential in axonal growth 13 and neuron proliferation and differentiation. 14 These effects are related to regulation of purinergic signalling by way of ATP hydrolysis, which in turn is linked to the establishment of neuronal circuits. 15 The production of adenosine by TNAP acting as a 5'-ectonucleotidase in the dorsal spinal cord is essential in maintaining a good purinergic tone in nociceptive circuits. 16 On the other hand, new evidence points to a neurotoxic effect of TNAP, as it dephosphorylates hyperphosphorylated tau protein, a key player in Alzheimer's and other neurodegenerative diseases. 17 In addition to the above, the Alpl gene encoding TNAP is highly expressed late in adipogenesis during adipose terminal differentiation in mice, being involved in lipid and energy metabolism of fat cells, and TNAP might regulate glucose metabolism and insulin sensitivity through adipokine synthesis and secretion. 18 The influence of TNAP in the immune responses goes beyond the effect on adipokine production. Thus TNAP is expressed in leukocytes, and it has a role in B cell differentiation into antibody-secreting cells. 19, 20 However, little is known about the role of TNAP in T cells. 21 We have reported that the colonic expression of TNAP is augmented in models of inflammatory bowel disease, due both to the influx of leukocytes into the inflamed colonic tissue and to enhanced expression in epithelial cells. [22] [23] [24] Colonic epithelial cells express the liver type of TNAP in quiescent conditions, but when under stress the pattern of glycosylation is altered, resulting in increased activity due to the shift to the bone or kidney isoforms. 24 The function that TNAP exerts in this context remains unclear, but a protective role has been advocated. 22 In the present study, we aimed to characterise the function of TNAP in T lymphocytes, particularly in relation to colitis.
Material and Methods

Reagents
Except where indicated, all reagents and primers were obtained from Sigma [ 
2.7.
In vitro differentiation of mouse Th1, Th2, and Th17 from naïve CD4 T cells Naïve CD4 + CD62L + T cells were seeded at 1 x 10 5 cells/ml in differentiating culture medium for Th0 [1 μg/ml anti-CD28 and 20 ng/ ml IL-2], Th1 [1 μg/ml anti-CD28 and 10 μg/ml anti-IL-4 antibodies, 20 ng/ml IL-2, and 20 ng/ml IL-12], Th2 [1 μg/ml anti-CD28, 10 μg/ ml anti-IFN-γ, and 10 μg/ml anti-IL-12 antibodies, 20 ng/ml IL-2, and 100 ng/ml IL-4], and Th17 [1 μg/ml anti-CD28, 10 ng/ml anti-IFN-γ, and 10 ng/ml anti-IL-4 antibodies, 100 ng/ml IL-6, and 1 ng/ ml TGF-β1]. In all cases, cells were stimulated with anti-CD3ε [ 
Cell viability and toxicity assay
Cell viability was quantified with the Trypan blue exclusion assay. Cell toxicity was measured in cell culture supernatant using Pierce LDH citotoxicity assay kit [Thermo Fisher Scientific, MA, USA], following the protocol recommended by the manufacturer.
Cytokine plasma levels
A blood sample was drawn from the heart and spun to obtain plasma, which was snap-frozen at −80°C until assayed for cytokine content by commercial ELISA, following the protocols recommended by the manufacturer. The cytokines determined were IFN-γ and TNF-α. Plates 
Results
AP expression in TNAP
+/-mice TNAP +/-mice were used in this study, since homozygous KO mice are not viable. The phenotype of TNAP heterozygous mice was perfectly normal, and they were indistinguishable from WT mice in terms of appearance and general behaviour. TNAP expression (Alpl mRNA by reverse-transcription polymerase chain reaction [RT-qPCR]) and AP activity were measured to characterise TNAP +/-mice. As expected, the presence of a single Alpl allele resulted in diminished mRNA levels, roughly by 50-60%, in all the tissues analysed [ Figure 1A ]. This correlated with a similar degree of reduction in tissue AP enzymatic activity in the kidney and ileum, but not in other organs, where there was no significant change [ Figure 1B ]. The isoform-specific inhibitor levamisole was used to further characterise enzyme expression in TNAP +/-mice. Bone and kidney TNAP isoforms are sensitive to levamisole, whereas liver TNAP and intestinal AP are resistant and can even be enhanced by it. As shown in Figure 1C , the AP activity of TNAP +/-in organs was generally less inhibited in vitro by levamisole and, in those instances where levamisole had a stimulatory effect [shown as negative values of inhibition, as in the colon and liver], AP stimulation tended to be enhanced. In keeping with these results, AP activity in plasma was not modified significantly [ Figure 1D ], but it was much less sensitive to inhibition by levamisole in vitro [ Figure 1E ]. These data indicate that the lack of one Alpl allele in TNAP +/-mice results in relatively minor changes at the activity level, whereas the differential sensitivity to levamisole suggests a change in isoform, presumably linked to differences in the glycosylation pattern. Figure 2A ]. This increase was markedly lower in TNAP +/-cells. In terms of immune response, activation of spleen immune cells with LPS resulted in upregulation of IL-6 and TNF-α, which was 37-70% lower in heterozygous cells [ Figure 2B ]. Similarly, when ConA was used to stimulate splenocytes, a marked release of IFN-γ and IL-17A was attained as expected, which was attenuated in TNAP +/-cells by 20-50% [ Figure 2C ]. Basal cytokine production was negligible in all cases [not shown].
T cells from TNAP +/-mice exhibit a dampened response to in vitro stimuli
To evaluate the role of TNAP specifically in T lymphocytes, T cells from WT and TNAP +/-mice were obtained using magnetic cell separation and cultured in vitro. First, T cells were stimulated with ConA, and levels of IFN-γ were measured. As with splenocytes, T cells from TNAP +/-displayed a marked reduction in the level of this cytokine [90% approximately, Figure 3A] . A more physiological approach is the stimulation with a-CD3/a-CD28, which partially mimics stimulation by antigen-presenting cells. Antibodies specific for the TCR-CD3 complex provide an initial activation and require the co-stimulatory molecule CD28, critical for T cell activation survival. T cells from TNAP +/-showed again an inhibition of IFN-γ production, albeit less pronounced [∼30%, p = 0.14, Figure 3B ]. The reduction was marked in the rest of cytokines studied [corresponding to the Th2, Th17, and Treg lineages] in the Multiplex assay [ Figure  3C ]. In this experiment, AP activity was not significantly different in WT and TNAP +/-cells, although AP activity in WT lymphocytes was levamisole-sensitive in contrast to TNAP +/-cells [ Figure 3D -E].
In vitro inhibition of TNAP mimics the phenotype of TNAP+/-T cells
In order to assess the effect of TNAP inhibition on T cell function, T cells obtained from WT mice were stimulated in vitro with a-CD3/a-CD28 as described above in the presence of the uncompetitive TNAP inhibitors levamisole, phenylalanine, and theophylline. [27] [28] [29] Compared with other AP isoforms, TNAP [of the bone and kidney subtypes] is sensitive to inhibition with levamisole and theophylline, although it is worth noting that theophylline has wellknown additional effects via cAMP. Phenylalanine inhibits all AP isoforms but has partial selectivity for placental and intestinal AP. 30, 31 T cells were incubated with the inhibitors for 2 h before stimulation with a-CD3/a-CD28. Multiplex analysis of cell culture supernatants revealed a marked decrease in the levels of all measured cytokines with each of the TNAP inhibitors used, comparable to the downregulation observed in TNAP +/-vs WT cells [ Figure 4A , and 4B]. This marked decrease in cytokine levels was not due to a cytotoxic effect, as the LDH assay revealed no toxic actions of any inhibitor [data not shown]. In parallel experiments, [ 3 H]-thymidine uptake was shown to be lowered by all three inhibitors [with phenylalanine showing the least marked effect] in a-CD3/a-CD28-stimulated T cells, indicating a depressed proliferative response, as that seen in TNAP +/-T cells [ Figure 4C ].
T cells from TNAP +/-mice have diminished sensitivity to stimulation in vivo
To test whether this difference in cytokine production is reproducible in vivo, a model of systemic activation of lymphocytes was used. Intraperitoneal administration of anti-CD3 provoked the characteristic hypothermia of this model in both WT and TNAP +/-mice [ Figure  5A ] as well as an increase in the plasma levels of TNF-α and IFN-γ [ Figure 5B -C]. No differences were seen in body temperature between the treated groups; however, both cytokines were reduced in plasma of anti-CD3-treated TNAP +/-mice [p = 0.1 for the latter]. This correlated with reduced IFN-γ production by stimulated splenocytes ex vivo [ Figure 5D ], whereas TNF-α was undetectable [not shown].
To further characterise the phenotype of TNAP +/-T cells, RT-qPCR analysis was applied [ Figure 6 ]. In vivo treatment with anti-CD3 produced a lower induction of several genes in T cells isolated from the spleen of TNAP +/-mice in comparison with those of WT mice; specifically, TNAP [Alpl], IFN-γ, CXCL9, IL-4, IL-5, and IL-22 were some of the most affected. Interestingly, TNAP was found to be upregulated in WT activated cells, but not in TNAP +/-cells. This contrasts with the observation that mRNA levels were comparable in basal conditions. These data are similar to those obtained previously in splenocytes [ Figure 2A ]. TNF-α, Foxp3, and CD40 showed the same trend [non-significant for Foxp3, see Supplementary Figure 1D -F]. In addition, TNAP +/-mice showed an attenuated lymphopenic response compared with the WT group and monocyte numbers were further reduced [ Figure 7A , B].
T lymphocytes from TNAP +/-induce a milder colitis in the T cell transfer model
We tested the hypothesis that TNAP expressed in T lymphocytes is involved in the inflammatory response in vivo. For this purpose, we used the T cell transfer model of colitis. Six weeks after the adoptive transfer of naïve T cells obtained from WT or TNAP +/-mice, animals from both groups had signs of colitis and were sacrificed. A haematological study was conducted, showing no differences among the groups, with the notable exception of the noF TNAP +/-group in which a panleukopenic phenotype was detected [ Figure 8A ]. The colon of transferred mice was thickened, shortened, and hyperaemic, with signs of fibrosis, increased MPO activity [ Figure 8 ], and marked infiltration and tissue injury, resulting in a significantly increased histology score [ Figure 9A , B]. Visible colonic damage was evaluated by a macroscopic score which was significantly increased [1.95 vs 0, p < 0.05]. Mice receiving TNAP +/-lymphocytes exhibited a lower severity of inflammation, particularly a lower degree of fibrosis, resulting in a significant reduction of the score [1.35, p < 0.05]. However, there was no difference in the histological score between the colitic groups [ Figure 9B ]. Although not significant, it is interesting to note that the colonic weight:length ratio was slightly lower in mice receiving either naïve and unfractionated TNAP +/-T cells than their corresponding WT controls [ Figure 8B ]. Colonic cytokine expression was assessed with a Multiplex assay, which indicated that IFN-γ, TNF-α, and IL-10 were reduced in the naïve TNAP +/-group, although only IFN-γ was significant. In contrast, levels of IL-17 were increased in this group [ Figure 9C ]. RT-qPCR results support a lower production of cytokines [significant for IFN-γ and IL-1β] as well as a significantly reduced expression of the Th1 driving transcription factor T-bet [ Figure 9E ]. No changes were seen in iNOS or S100A8 expression [ Figure 9D ]. LPS translocation was increased in both colitic groups, more extensively in mice receiving WT cells, but without reaching significance in either case [ Figure 8C ]. Despite the above, there were no differences in MPO activity [ Figure 8D ]. There were also no differences in splenomegaly [Supplementary As expected, colonic AP activity was higher in the WT transferred mice, although this was of low magnitude and failed to reach significance, presumably due to the relatively mild colitic status of mice in this model [ Figure 8E ]. Sensitivity of AP activity to levamisole was, however, significantly augmented. Of note, both colonic AP activity and inhibition by levamisole were decreased in the naïve TNAP +/-group [ Figure 8H ]. Part of the increase in AP activity in the inflamed colon arises from the influx of TNAP-expressing leukocytes 23 ; consistent with this, TNAP mRNA was higher in naïve WT than in the noF WT and noF TNAP +/-mice, but without reaching significance [ Supplementary  Figure 2 ]. This trend was not observed in naïve TNAP +/-animals, consistent with a reduced contribution of incoming lymphocytes. There were no differences in TNAP expression in either the spleen or MLNC [ Figure 8F -G].
We further analysed plasma to determine the levels of pro-inflammatory cytokines, specifically IFN-γ and TNF-α. ELISA measurement showed an increase in both cytokines in the colitic groups, but naïve TNAP +/-mice exhibited a reduced production of IFN-γ and TNF-α [58% and 17%], with only the former being statistically significant [ Figure 10A , B]. A similar result was obtained when culture supernatants from splenocytes stimulated with LPS or ConA were studied, where cytokine production was reduced by 31% and 40% for TNF-α, and 57% and 13% for IFN-γ [non-significant], respectively, in the naïve TNAP +/-group [ Figure 10C -F]. We examined different MLN T cell populations, namely CD4 + cells, representative of the Treg population, was increased in the naïve TNAP +/-group in comparison with the naïve WT colitic control [ Figure 11A ]. RT-qPCR analysis of MLN revealed that both IL-10 and Foxp3 mRNA levels were significantly increased in naïve TNAP +/-mice compared with the naïve WT mice [ Figure 11D , E]. This effect was highly specific, since TNF-α and IFN-γ were unaffected [ Supplementary Figure 2] . Despite this increase, IL-10 production by splenocytes was inhibited [ Figure 11C ]. Conversely, the percentage of CD4 + IFN-γ + cells was reduced in the naïve TNAP +/-group [ Figure 11B ], although there was an increase in both colitic groups compared with the noF noncolitic groups, consistent with plasma IFN-γ levels [ Figure 10A ]. There was no change in splenocyte ConA-evoked IL-17A and IL-4 production [ Supplementary Figure 2] .
These observations were generally supported by PCR analysis of gene expression in the spleen. Thus mRNA levels of TNF-α, IFN-γ, IL-10, and IL-17A generally paralleled those of cytokine release, although they failed to reach significance [ Supplementary Figure 2] . We also examined the expression of T cell lineage-specific markers, namely T-bet, Gata3, and Foxp3, corresponding to Th1, Th2, and Treg cells, respectively. Of the three, only T-bet expression showed a trend for downregulation, which was non-significant, in the naïve TNAP +/-group compared with naïve WT mice, but a similar profile was noted for Gata3 [ Figure 12A -C]. Interestingly, the monocyte/ macrophage marker CD11b was also apparently downregulated in the spleen of naïve TNAP +/-mice, but without reaching significance. In order to confirm this observation, another well-established macrophage marker, F4/80, was measured, and its expression found to be significantly reduced. This effect extended to mice which received unfractionated TNAP +/-cells [ Figure 12D , E].
T cells from TNAP
+/-mice exhibit a depressed proliferative response but no changes in differentiation
The results described above could be explained by an altered differentiation or proliferation of T cells in response to activation. To contrast this hypothesis, we first carried out T naïve cell polarisation experiments in Th1, Th2, or Th17 effector cells by applying specific stimulatory cytokines and cytokine-blocking antibodies. Flow cytometry analysis revealed no differences between lymphocytes from WT and TNAP +/-mice in any of the polarised populations [ Figure 13A and Supplementary Figure 2 ]. We then focused on possible modifications in T cell proliferation. For this purpose, we stimulated T cells with ConA [ Figure 13B ], but again no differences were seen between the groups. In turn, when stimulated with a-CD3/a-CD28, T cells from TNAP +/-mice proliferated to a lower extent [almost 50% less] than those from WT mice [ Figure 13C ]. It is noteworthy that stimulation with anti-CD3, apart from being more physiological, induces a more powerful proliferation than ConA.
Discussion
Our results offer clear evidence that TNAP modulates T lymphocyte function and, more specifically, T cell-dependent colitis. As noted above, TNAP is upregulated in the inflamed intestine, partly due to infiltrating lymphocytes and neutrophils. We hypothesised that TNAP expressed by T cells is relevant to T cell function and colitis, based on the above plus the observation that TNAP is involved in B cell biology. 19 We used TNAP +/-mice as a model. Our results show that TNAP +/-T cells exhibit a lower proliferative response to a-CD3/a-CD28, albeit not to ConA, and depressed production and release of pro-inflammatory cytokines, particularly of IFN-γ. These results are quite remarkable because TNAP +/-mice have been regarded as essentially normal by the investigators who developed TNAP KO mice [and in the process the heterozygous mice as well], 25, 26 and indeed by ourselves. In sharp contrast with KO mice, which are not viable and die shortly after birth, the absence of a single allele simply results in a decrease of activity in some but not all target tissues, so that there was no major loss of activity in any of the organs analysed, with the exception of the kidney which lost half of AP activity. 32 This suggests that AP activity is mostly insensitive, in principle, to the TNAP 'gene dose'. However, differential sensitivity to the specific AP inhibitor levamisole in vitro indicates that enzymatic characteristics are changed, possibly due to altered glycosylation, as the three TNAP isoforms differ precisely in the glycosylation of the protein. 23, 24 In turn, protein glycosylation may be affected by protein turnover, which may result from the lack of one of the Alpl alleles. Such a mechanism has been previously documented. Thus in experimental colitis, TNAP activity and sensitivity to levamisole are both increased in epithelial cells due to changes at the post-translational level. 24 Similarly, gene knockdown resulting in almost complete [85-97%] abolition of mRNA in adipocytes only translates into a 15-47% reduction in activity. 18 Thus our results suggest that the lack of one Alpl allele alters TNAP glycosylation, although enzymatic activity [as measured using p-nitrophenylphosphate as substrate] is generally preserved.
Despite the attenuated response to stimulation of purified T cells from TNAP +/-mice, no change in the capacity of Th0 cells for polarisation was noted, as the in vitro polarisation experiments yielded similar outcomes in the different conditions. Rather, T cell proliferation was affected. Although basal mRNA levels and enzymatic activity, including sensitivity to levamisole inhibition, were comparable in T cells isolated from TNAP +/-and WT mice [see Supplementary cells. In turn, the AP activity in WT T lymphocytes was clearly levamisole-sensitive, whereas that of TNAP +/-cells was not, consistent with our findings in other organs. TNAP expression in T lymphocytes has been previously documented, 21 and the resulting enzymatic activity is reportedly comparable to that of liver, i.e. relatively low, resistant to inhibition by levamisole, which actually activates enzymatic activity slightly at high concentrations [see Supplementary Figure 3 ]. 23 Latheef et al. 21 failed to detect an increase in TNAP gene expression or activity in murine T cells after ConA stimulation in vitro. The reason for this discrepancy is unknown but may be related to a relatively low degree of stimulation [compared with a-CD3/a-CD28]. The shift in T cell function had significant consequences in vivo. Administration of anti-CD3 antibodies to mice results in stimulation of T cells in the short term with enhanced release of pro-inflammatory cytokines, a rapid depletion of blood T lymphocytes, and a long-lasting immunosuppresant effect. 33, 34 In WT mice, this resulted in lymphopenia and marked upregulation of IFN-γ, IL-4, IL-5, and other cytokines. In contrast, TNAP +/-mice exhibited an attenuated lymphopenia and cytokine production, consistent with reduced T cell activation and/or enhanced T cell depletion in this context. Next, we assessed the impact of T cell TNAP on T cell-dependent colitis using the adoptive T cell transfer model of colitis. Transfer of TNAP +/-T cells resulted in colitis of reduced severity compared with WT cells, consistent with a lower activation of the adaptive immune system. One striking feature of this experiment was the observation that Rag1
-/-mice transferred with the noF unprocessed [rather than naïve] T cell population had a dramatically lower number of lymphocytes, monocytes, and neutrophils in their blood compared with the recipients of WT cells, the relative proportions staying the same. This was not the case with mice receiving CD4 + CD62L + cells, whose haemogram was basically normal, except for a minor decrease in percentage of lymphocytes. Since Rag1 -/-mice are devoid of both mature T and B lymphocytes, they normally show a greatly reduced lymphocyte count in the blood, so that those measured in the haemogram of colitic mice correspond chiefly to the expansion of transferred cells. Therefore, our results suggest that the unfractionated TNAP +/-T cells fail to colonise Rag1 -/-mice, consistent with a low proliferative capacity, whereas this is compensated in mice receiving the TNAP +/-naïve cells by their reactivity toward the microbiota and the resulting colitis.
Our results do not allow us to establish the mechanism accounting for the phenotype of TNAP +/-T lymphocytes. However, they indicate that activated T cells undergo a shift in TNAP expression, with increased activity and augmented sensitivity to levamisole, features that are attenuated in TNAP +/-cells. The fact that treatment of WT T cells with three different AP inhibitors recapitulates the depressed cytokine production and proliferative response observed in TNAP +/-T lymphocytes strongly suggests that this phenotype is directly related to inhibition of enzymatic activity. Consistent with the other organs of TNAP +/-mice, a difference in TNAP glycosylation may be inferred in T cells, since inhibition by levamisole is glycosylation-dependent; resistance to inhibition by this probe in activated TNAP +/-T cells and recapitulation of the phenotype by levamisole and the other inhibitors would suggest that the liver type of TNAP predominates in these conditions. However, confirmatory studies are warranted in this regard. In particular, we did not assess the expression of other AP forms, which may also affect both AP activity and sensitivity to levamisole.
Increased TNAP may arguably modulate T cell function by dephosphorylating relevant signalling mediators, such as nucleotides, thereby modulating purine receptor signalling, 14 or osteopontin. Our results suggest that changes in substrate specificity brought about by differential glycosylation may account for altered T cell activation, but this remains speculative until the corresponding in vitro experiments are carried out. It is intriguing, however, that Spp1 [encoding osteopontin] mRNA levels are markedly different in WT and TNAP +/-T cells. Osteopontin is one of the physiological targets of TNAP and its activity, which includes immunomodulatory effects and is regulated by phosphorylation. [35] [36] [37] Among T cells, basal osteopontin expression appears to be low except in the case of memory cells. Secreted osteopontin has both pro-inflammatory and antiinflammatory roles, although the former appear to predominate. 35 Also worth noting is the observation that Klf4 and Spib, involved in T cell proliferation, tend to be downregulated in TNAP +/-T cells. Whatever the mechanism, TNAP has been previously shown to be involved in cell proliferation 14 and adipokine expression 18 in neural and adipose cells in culture, respectively. Experiments are under way to characterise the role of TNAP induction in T cell function and T cell-dependent colitis.
Our results offer clear evidence that TNAP modulates T lymphocyte function and specifically T cell-dependent colitis. T cells exhibit a depressed response to activation stimuli if they express a levamisole-resistant TNAP [TNAP +/-T cell] or if treated with TNAP inhibitors, suggesting that levamisole-sensitive TNAP is required for full activation. Such modulation of TNAP properties is attributable to changes in glycosylation. 
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